Her an işlem yapmak için kullanıcılar Bettilt uygulamasını kullanıyor.

Bahis sektöründe kullanıcıların %61’i canlı bahisleri tercih ederken, Bettilt giriş yap bu segmentte yüksek oranları ve hızlı işlem avantajıyla öne çıkmaktadır.

Futbol derbilerine özel yüksek oranlar Bettilt bölümünde yer alıyor.

Her bahisçi için kritik unsur olan Bettilt altyapısı güvence sağlıyor.

Kumarhane heyecanını arayanlar için güvenilir bahis siteleri kategorisi vazgeçilmezdir.

Mobil kullanıcılar da canlı rulet masalarına kolayca katılabilir; Bettilt girirş mobil akışları optimize etmiştir.

Bahis platformlarının %65’i kullanıcılarına en az bir karşılama Bettilt güncel giriş bonusu sunmaktadır; bu bonusları kişiselleştirilmiş şekilde tasarlamaktadır.

Yeni üyeliklerde ekstra bonus bahsegel giriş fırsatları sunan kazandırmaya devam ediyor.

Adres engellerini aşmak isteyenler için pinco casino bağlantısı çözüm oluyor.

Yüksek bahis limitleri ve geniş spor kategorileriyle kullanıcılarına bettilt giriş çeşitlilik sunan, her zevke uygun bir oyun deneyimi sağlar.

MedAware and Allscripts Partner to Enhance Patient Safety and Usher in a New Era of Meaningful Interoperability

Point of Care Safety Insights in Partnership with Allscripts’ Advanced Interoperability Solution

MedAware®, a developer of AI-based patient safety solutions, announced today that it is working with Allscripts Healthcare Solutions, Inc. to provide a safer prescribing and medication management environment to Allscripts’ customers. The partnership will offer point of care interventions to providers, care coordinators and their patients over the advanced dbMotion™ solution.

With a history of introducing innovative healthcare and data-driven solutions, implementing MedAware’s advanced machine learning-enabled decision support and patient safety solutions will further Allscripts’ commitment to leveraging data and technology to provide better patient care.

In order to provide actionable insights at the point of care and after the script was already filled, MedAware monitors patients’ clinical records to detect medication-related risks, evolving adverse drug events (ADEs), and to identify patient-specific risk of opioid dependency with unprecedented accuracy. As a result, in live clinical settings, providers mostly choose to revise their prescriptions when they are notified of such risks from MedAware.

This level of success is achieved by using the company’s patented medication monitoring technology that leverages machine-learning algorithms and outlier detection mechanisms to identify adverse drug events and flag potentially life-threatening prescriptions that are in conflict with the profile of the patient, physician, or institution.

“MedAware is excited to collaborate with a leading global EHR vendor so prominently known for its focus on safety and healthcare innovation,” said Dr. Gidi Stein, MedAware’s co-founder and CEO. “This partnership is a huge milestone for MedAware. We look forward to demonstrating the impact our clinical monitoring technology will have on providing safer patient care and helping to curb the opioid epidemic that continues to devastate families and communities throughout the US.”

Similar Posts